{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:56:24Z","timestamp":1793480184930,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001454","name":"American Epilepsy Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001454","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001771","name":"Tuberous Sclerosis Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["F32 HD095567"],"award-info":[{"award-number":["F32 HD095567"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS056872"],"award-info":[{"award-number":["R01 NS056872"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS086329"],"award-info":[{"award-number":["R01 NS086329"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.eplepsyres.2022.106890","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T16:31:26Z","timestamp":1645201886000},"page":"106890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Inhibition of MEK-ERK signaling reduces seizures in two mouse models of tuberous sclerosis complex"],"prefix":"10.1016","volume":"181","author":[{"given":"Lena H.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Leiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dekun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Roberds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique","family":"Bordey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2022.106890_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124471","article-title":"MAP\/ERK signaling in developing cognitive and emotional function and its effect on pathological and neurodegenerative processes","volume":"21","author":"Albert-Gasco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00280-011-1620-1","article-title":"Pilot study of PD-0325901 in previously treated patients with advanced melanoma, breast cancer, and colon cancer","volume":"68","author":"Boasberg","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/brain\/awz370","article-title":"The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas","volume":"143","author":"Bongaarts","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2022.106890_bib4","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106890_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10010023","article-title":"mTOR cross-talk in cancer and potential for combination therapy","volume":"10","author":"Conciatori","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.eplepsyres.2022.106890_bib6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ejpn.2012.05.004","article-title":"Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations","volume":"16","author":"Curatolo","year":"2012","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib8","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2022.106890_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ijc.31052","article-title":"The impact of P-glycoprotein and breast cancer resistance protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors","volume":"142","author":"de Gooijer","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.eplepsyres.2022.106890_bib10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1158\/0008-5472.CAN-03-3277","article-title":"Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions","volume":"64","author":"Han","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib11","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1038\/ncomms11753","article-title":"Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement","volume":"7","author":"Hsieh","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib12","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1528-1167.2007.01117.x","article-title":"Epilepsy surgery in tuberous sclerosis: a systematic review","volume":"48","author":"Jansen","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106890_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1469-1809.2003.00012.x","article-title":"Tuberous sclerosis: from tubers to mTOR","volume":"67","author":"Kwiatkowski","year":"2003","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","article-title":"ERK signalling: a master regulator of cell behaviour, life and fate","volume":"21","author":"Lavoie","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib15","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1158\/0008-5472.CAN-06-4798","article-title":"Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer","volume":"67","author":"Ma","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.stem.2011.09.008","article-title":"Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions","volume":"9","author":"Magri","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.eplepsyres.2022.106890_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0969-9961(03)00127-X","article-title":"Expression of ICAM-1, TNF-alpha, NF kappa B, and MAP kinase in tubers of the tuberous sclerosis complex","volume":"14","author":"Maldonado","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib18","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00381-010-1128-8","article-title":"Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges","volume":"26","author":"Moavero","year":"2010","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib19","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1038\/sj.emboj.7601911","article-title":"ERK activation causes epilepsy by stimulating NMDA receptor activity","volume":"26","author":"Nateri","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib20","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1523\/JNEUROSCI.2260-18.2019","article-title":"mTOR hyperactivity levels influence the severity of epilepsy and associated neuropathology in an experimental model of tuberous sclerosis complex and focal cortical dysplasia","volume":"39","author":"Nguyen","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/neup.12242","article-title":"Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia","volume":"36","author":"Patil","year":"2016","journal-title":"Neuropathology"},{"key":"10.1016\/j.eplepsyres.2022.106890_bib23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuron.2009.01.001","article-title":"MAP'ing CNS development and cognition: an ERKsome process","volume":"61","author":"Samuels","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.eplepsyres.2022.106890_bib24","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3892\/ijmm.2017.2962","article-title":"The extracellular signal-regulated kinase 1\/2 pathway in neurological diseases: a potential therapeutic target (review)","volume":"39","author":"Sun","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrn1346","article-title":"MAPK cascade signalling and synaptic plasticity","volume":"5","author":"Thomas","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.10283","article-title":"Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures","volume":"52","author":"Uhlmann","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib27","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bbamcr.2006.11.009","article-title":"Clinical experience of MEK inhibitors in cancer therapy","volume":"1773","author":"Wang","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.eplepsyres.2022.106890_bib28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1200\/JCO.20.02220","article-title":"NF106: a neurofibromatosis clinical trials consortium phase II trial of the MEK inhibitor mirdametinib (PD-0325901) in adolescents and adults with NF1-related plexiform neurofibromas","volume":"39","author":"Weiss","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib29","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106890_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuron.2014.09.009","article-title":"MEK-ERK1\/2-dependent FLNA overexpression promotes abnormal dendritic patterning in tuberous sclerosis independent of mTOR","volume":"84","author":"Zhang","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.eplepsyres.2022.106890_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay0289","article-title":"Filamin A inhibition reduces seizure activity in a mouse model of focal cortical malformations","volume":"12","author":"Zhang","year":"2020","journal-title":"Sci. Transl. Med."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121122000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121122000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T02:18:07Z","timestamp":1741918687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121122000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":31,"alternative-id":["S0920121122000419"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.106890","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of MEK-ERK signaling reduces seizures in two mouse models of tuberous sclerosis complex","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.106890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106890"}}